Influence of Clinical and Histological Features on Actuarial Renal Survival in Adult Patients With Idiopathic IgA Nephropathy, Membranous Nephropathy, and Membranoproliferative Glomerulonephritis: Survey of the Recent Literature
References (72)
- et al.
Toward individual prognosis of IgA nephropathy
Kidney Int
(1986) - et al.
Prognostic factors in mesangial IgA glomerulonephritis. An extensive study with univariate and multivariate analysis
Am J Kidney Dis
(1991) - et al.
IgA nephropathy. Presentation, clinical course, and prognosis in children and adults
Am J Kidney Dis
(1984) - et al.
Long-term prognosis of idiopathic membranous glomerulonephritis
Study of 116 untreated patients. Am J Med
(1979) - et al.
The natural history of untreated patients
Kidney Int
(1988) - et al.
Reassessment of treatment results in membranoproliferative glomerulonephritis, with emphasis on life-table analysis
Am J Kidney Dis
(1989) - et al.
Idiopathic mesangiocapillary glomerulonephritis
Comparison of types I and II in children and adults and long-term prognosis. Am J Med
(1983) - et al.
IgA nephropathy. Morphologic predictors of progressive renal disease
Hum Pathol
(1982) - et al.
Proteinuria in IgA nephropathy
Kidney Int
(1988) - et al.
Membranous glomerulonephritis. Long-term serial observations on clinical course and morphology
Kidney Int
(1973)
Prognosis and treatment of membranous nephropathy
Kidney Int
(1986)
Clinical features and natural history in adults with IgA nephropathy
Am J Kidney Dis
(1988)
Is glomerulosclerosis a consequence of altered glomerular permeability?
Kidney Int
(1990)
Progression of renal insufficiency Role of blood pressure
Kidney Int
(1989)
The consequences oftubulo-interstitial changes for renal function in glomerulonephritis
Pathol Res Pract
(1990)
Characterization of interstitial infiltrating cells in Berger’s disease
Am J Kidney Dis
(1988)
Immune mechanisms in idiopathic membranous nephropathy The role of interstitial infiltrates
Am J Kidney Dis
(1989)
Mononuclear cell activation and decreased renal function in IgA nephropathy with crescents
Kidney Int
(1990)
Expression of HLA-DQ, DR, and DP antigens in normal kidney and glomerulonephritis
Kidney Int
(1989)
The long-term outcome of glomerular diseases
Primary glomerular diseases
Design and analysis of randomized clinical trials requiring prolonged observation of each patient II
Analysis and examples. Br J Cancer
(1977)
Regression models and life tables
J R Stat Soc (B)
(1972)
The clinical course of mesangial IgA associated nephropathy in adults
Q J Med
(1984)
Idiopathic IgA mesangial nephropathy
Clinical and histological study of 374 patients. Medicine (Baltimore)
(1985)
Primary IgA nephropathy: From the first described cases to the present
Semin Nephrol
(1987)
Natural history of IgA nephropathy in patients followed up for more than ten years in Spain
Semin Nephrol
(1987)
On the importance of morphological and clinical parameters in the long-term prognosis of 239 patients
Am J Nephrol
(1990)
Development of hypertension in IgA nephropathy as a marker of a poor prognosis
Am J Nephrol
(1990)
Longterm prognosis and prognostic indices of IgA nephropathy in juvenile and in adult Japanese
Clin Nephrol
(1987)
The natural history of IgA nephritis in Singapore
Clin Nephrol
(1986)
La glomerulonefrite membranosa. Evoluzione e prognosi in 85 pazienti non trattati
G Ital Nefrol
(1988)
Survival in idiopathic membranous glomerulonephritis
Clin Nephrol
(1986)
Long-term outcome of idiopathic membranous nephropathy with nephrotic syndrome
Nephrol Dial Transplant
(1987)
Longterm prognosis of chronic idiopathic membranous glomerulonephritis
An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol
(1989)
Idiopathic membranous glomerulonephritis: Long-term follow-up in 139 cases
Clin Nephrol
(1988)
Cited by (192)
The Evolving Role of Novel Biomarkers in Glomerular Disease: A Review
2021, American Journal of Kidney DiseasesIgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank
2020, Kidney International ReportsEnd-Stage Renal Disease and Mortality Outcomes Across Different Glomerulonephropathies in a Large Diverse US Population
2018, Mayo Clinic ProceedingsCitation Excerpt :However, it remains to be determined whether individual GNs are differentially affected by the same risk factors.26 Identifying additional disease-specific factors may provide more insights to optimize management.10,12,26-28 The information from our EHR-based cohort has the potential to affect patient care throughout large health systems such as Kaiser Permanente.
Severe Adverse Effects Associated With Corticosteroid Treatment in Patients With IgA Nephropathy
2017, Advances in Clinical Chemistry
Copyright © 1992 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.